The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent

Clinical Pharmacology and Therapeutics

Volumn 63, Issue 1, 1998, Pages 48-53

  Kaplan, Bruce ^a   Meier Kriesche, Herwig Ulf ^a   Napoli, Kimberly L ^a   Kahan, Barry D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; PREDNISONE; RAPAMYCIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GRAFT REJECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; KIDNEY TRANSPLANTATION; MALE; MICROEMULSION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; CROSS-OVER STUDIES; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; EMULSIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYENES; SIROLIMUS;

EID: 13144256680     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(98)90120-5     Document Type: Article

References (18)

1. Vezina C, Kudelski A, Sehgal SN. Rapamycin (ay-22,989), a new antifungal antibiotic; I: Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo) 1975;28:721-6.
2. Sehgal SN, Baker H, Vezina C. Rapamycin (ay-22,989), a new antifungal antibiotic; II: Fermentation, isolation and characterization. J Antibiot (Tokyo) 1975;28:727-32.
3. Murgia MG, Jordan S, Kahan BD. The side effect profile of rapamycin: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients. Kidney Int 1996;49:209-16.
4. Zimmerman J, Kahan BD. The pharmacokinetics of rapamycin in stable renal transplant patients after multiple oral dose administration. J Clin Pharmacol 1997;37:405-15.
5. Fryer J, Yatscoff RW, Pascoe EA, Thliveris J. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model. Transplantation 1993;55:340-5.
6. Granger DK, Cromwell JW, Chen SC, Goswitz JJ, Morrow DT, Beierle FA, et al. Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapy. Transplantation 1995;59: 183-6.
7. Ochiai T, Gunji Y, Nagata M, Komori A, Asano T, Isono K. Effects of rapamycin in experimental organ allografting. Transplantation 1993;56:15-9.
8. Sattler M, Guengerich FP, Yun CH, Christians U, Sewing KF. Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab Dispos 1992;20: 753-61.
9. Wacher VJ, Wu CY, Benet LZ. Overlapping substrate specificities and time distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity on cancer chemotherapy. Mol Carcinog 1995;13:129-34.
10. Gomez DY, Wacher VJ, Tomlanovich SJ, Hebert MF, Benet LZ. The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine. Clin Pharmacol Ther 1995;58:15-9.
11. Wu CY, Benet LZ, Hebert MF, Gupta SK, Rowland M, Gomex DY, et al. Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine. Clin Pharmacol Ther 1995; 58:492-7.
12. Napoli KL, Kahan BD. Sample clean-up and high-performance liquid Chromatographic techniques for measurement of whole blood rapamycin concentrations. J Chromatogr B Biomed Appl 1994;654:111-20.
13. Napoli KL, Kahan BD. Routine clinical monitoring of rapamycin (rapamycin) whole-blood concentrations by HPLC with ultraviolet detection. Clin Chem 1996; 42:1944-8.
14. Lindholm A, Kahan BD. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplant. Clin Pharmacol Ther 1993;54:205-18.
15. Ritschel WA. Handbook of basic pharmacokinetics. 4th ed. Hamilton (IL): Drug Intelligence Publications; 1992. p. 356.
16. Norusis MJ. SPSS for Windows users guide. Chicago: SPSS; 1993. p. 311.
17. Takeguchi N, Koike M, Matsui W, Kashiwagura T, Kawahara K. Inhibition of the multidrug efflux pump in isolated hepatocyte couplets by immunosuppressants FK506 and cyclosporine. Transplantation 1993; 55:646-50.
18. Kovarik JM, Mueller EA, van Bree JB, Arns W, Renner E, Kutz K. Within-day consistency in cyclosporine pharmacokinetics from a microemulsion formulation in renal transplant patients. Ther Drug Monit 1994;16:232-7.